Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Clinical trial NCT01295710 · COMPLETED
Trial details
- NCT number
- NCT01295710
- Sponsor
- Neovii Biotech
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-10
- Primary completion
- 2015-10-15
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.